Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
University of Texas Southwestern Medical Center · NCT05147909
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–80 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 124
- US sites recruiting
- 1
- Study start
- September 14, 2022
- Record last updated
- February 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Studies in mice demonstrated that dietary phosphate (Pi) loading that mimic the level of US adult consumption leads to reduced spontaneous locomotor activity, exercise capacity, and reduced resting metabolic rate when in normal mice by impairing skeletal muscle mitochondrial function and fat oxidation. However, relevance of this findings in humans remains unknown.
Being studied: Sodium Phosphate; Sodium Chloride
Conditions: Physical Inactivity; Phosphate Overload; Visceral Obesity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
The randomized crossover trial will be performed in on otherwise healthy subjects without diabetes mellitus, chronic kidney disease (CKD), preexisting cardiovascular disease or treatment with any vasoactive agent that might alter cardiovascular responses to exercise.
Exclusion Criteria
- history of cardiopulmonary disease or chronic kidney disease,
- treatment with antihypertensive medications,
- estimated glomerular filtration rate (eGFR) \< 60 mL/min/1.73m2, (4) diabetes mellitus or other systemic illness,
(5) pregnancy, (6) hypersensitivity to sodium phosphate, (7) any history of substance abuse or current cigarette use, (8) any history of psychiatric illness, (9) history of active malignancy, (10) serum phosphorus \< 2.4 or > 4.5 mg/dL.
Recruiting US locations
University of Texas Southwestern
Dallas, TX 75209
Site contact: John Giacona, PA-C
Study contacts (from the official record)
- John Giacona, PA-C · 2146484403 · john.giacona@utsouthwestern.edu
Similar studies in Texas
All weight loss studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- Dallas, TX + 1 other US site
- Eligibility basics
- Ages 18–60 · Women only
- RecruitingHealthy volunteersPhase 1
A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
Eli Lilly and Company
- Location
- Dallas, TX + 1 other US site
- Eligibility basics
- Ages 18–65